CoChat
Sign Up
Cited by 22

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Exosomes: efficient macrophage-related immunomodulators in chronic lung diseases

Kang, Jianxiong, Hua, Peiyan, Wu, Xiaojing, Wang, Bin·2024·Frontiers in Cell and Developmental Biology
DOI 10.3389/fcell.2024.1271684PMC PMC11035777
Open this paper in CoChat — free account

Abstract

Macrophages, the predominant immune cells in the lungs, play a pivotal role in maintaining the delicate balance of the pulmonary immune microenvironment. However, in chronic inflammatory lung diseases and lung cancer, macrophage phenotypes undergo distinct transitions, with M1-predominant macrophages promoting inflammatory damage and M2-predominant macrophages fostering cancer progression. Exosomes, as critical mediators of intercellular signaling and substance exchange, participate in pathological reshaping of macrophages during development of pulmonary inflammatory diseases and lung cancer. Specifically, in inflammatory lung diseases, exosomes promote the pro-inflammatory phenotype of macrophages, suppress the anti-inflammatory phenotype, and subsequently, exosomes released by reshaped macrophages further exacerbate inflammatory damage. In cancer, exosomes promote pro-tumor tumor-associated macrophages (TAMs); inhibit anti-tumor TAMs; and exosomes released by TAMs further enhance tumor proliferation, metastasis, and resistance to chemotherapy. Simultaneously, exosomes exhibit a dual role, holding the potential to transmit immune-modulating molecules and load therapeutic agents and offering prospects for restoring immune dysregulation in macrophages during chronic inflammatory lung diseases and lung cancer. In chronic inflammatory lung diseases, this is manifested by exosomes reshaping anti-inflammatory macrophages, inhibiting pro-inflammatory macrophages, and alleviating inflammatory damage post-reshaping. In lung cancer, exosomes reshape anti-tumor macrophages, inhibit pro-tumor macrophages, and reshaped macrophages secrete exosomes that suppress lung cancer development. Looking ahead, efficient and targeted exosome-based therapies may emerge as a promising direction for treatment of pulmonary diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcell.2024.1271684

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Exosome production process, contents, and delivery: the process initiates with invagination of the plasma membrane, forming early sorting endosomes (ESEs) that encapsulate extracellular components. These ESEs can fuse with intracellularly synthesized substances or exchange biomaterials, leading to the formation of late sorting endosomes (LSEs). Further maturation gives rise to intracellular multivesicular bodies (MVBs), from which intraluminal vesicles (ILVs) are selectively sorted and eventually released into the extracellular space as extracellular vesicles. In addition, three forms of extracellular vesicle uptake by recipient cells were described, including membrane fusion, receptor binding (signal transduction), and endocytosis.
FIGURE 1 Exosome production process, contents, and delivery: the process initiates with invagination of the plasma membrane, forming early sorting endosomes (ESEs) that encapsulate extracellular components. These ESEs can fuse with intracellularly synthesized substances or exchange biomaterials, leading to the formation of late sorting endosomes (LSEs). Further maturation gives rise to intracellular multivesicular bodies (MVBs), from which intraluminal vesicles (ILVs) are selectively sorted and eventually released into the extracellular space as extracellular vesicles. In addition, three forms of extracellular vesicle uptake by recipient cells were described, including membrane fusion, receptor binding (signal transduction), and endocytosis.CC BY · PubMed Central
FIGURE 2 Pathogenesis and treatment of exosome-associated inflammatory lung disease: in inflammatory lung diseases, exosomes can be secreted by damaged airway epithelial cells, prompting macrophages to differentiate toward the pro-inflammatory phenotype and suppressing anti-inflammatory differentiation; while pro-inflammatory macrophages in turn use exosomes for further airway epithelial damage, fibroblast activation, and activation of other immune cells, forming a vicious circle to amplify inflammation and injury. However, the treatment of inflammatory lung diseases is delivered to macrophages through a variety of stem cell exosomes and synthetic drug-encapsulated exosomes, which induce anti-inflammatory differentiation and inhibit pro-inflammatory differentiation of macrophages, or the use of anti-inflammatory macrophage-secreted exosomes that act on other cells to mitigate the damage and destruction of lung tissue.
FIGURE 2 Pathogenesis and treatment of exosome-associated inflammatory lung disease: in inflammatory lung diseases, exosomes can be secreted by damaged airway epithelial cells, prompting macrophages to differentiate toward the pro-inflammatory phenotype and suppressing anti-inflammatory differentiation; while pro-inflammatory macrophages in turn use exosomes for further airway epithelial damage, fibroblast activation, and activation of other immune cells, forming a vicious circle to amplify inflammation and injury. However, the treatment of inflammatory lung diseases is delivered to macrophages through a variety of stem cell exosomes and synthetic drug-encapsulated exosomes, which induce anti-inflammatory differentiation and inhibit pro-inflammatory differentiation of macrophages, or the use of anti-inflammatory macrophage-secreted exosomes that act on other cells to mitigate the damage and destruction of lung tissue.CC BY · PubMed Central
FIGURE 3 Pathogenesis and treatment of exosome-associated lung cancer: lung cancer cells use exosomes to alter macrophage subpopulations to form a tumor microenvironment, and dysregulated macrophages facilitate a variety of malignant behaviors such as growth, metastasis, and drug resistance of lung cancer cells through exosomes. In contrast, treatment of lung cancer can begin by awakening anti-tumor macrophages in macrophages and inhibiting tumor-assisting macrophages, and anti-tumor macrophages will also inhibit the proliferation and development of tumor cells through exosomes.
FIGURE 3 Pathogenesis and treatment of exosome-associated lung cancer: lung cancer cells use exosomes to alter macrophage subpopulations to form a tumor microenvironment, and dysregulated macrophages facilitate a variety of malignant behaviors such as growth, metastasis, and drug resistance of lung cancer cells through exosomes. In contrast, treatment of lung cancer can begin by awakening anti-tumor macrophages in macrophages and inhibiting tumor-assisting macrophages, and anti-tumor macrophages will also inhibit the proliferation and development of tumor cells through exosomes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 120

  1. Aegerter, 2022, Biology of lung macrophages in health and disease, Immunity, 55, 1564, 10.1016/j.immuni.2022.08.010 · DOI
  2. Ban, 2023, Macrophage-derived exosomal lncrna Mstrg.91634.7 inhibits fibroblasts activation by targeting Pink1 in silica-induced lung fibrosis, Toxicol. Lett., 372, 36, 10.1016/j.toxlet.2022.10.004 · DOI
  3. Basak, 2023, Tumor-associated macrophages: an effective player of the tumor microenvironment, Front. Immunol., 14, 1295257, 10.3389/fimmu.2023.1295257 · DOI
  4. Bebelman, 2018, Biogenesis and function of extracellular vesicles in cancer, Pharmacol. Ther., 188, 1, 10.1016/j.pharmthera.2018.02.013 · DOI
  5. Broad, 2023, Unraveling multilayered extracellular vesicles: speculation on cause, J. Extracell. Vesicles, 12, e12309, 10.1002/jev2.12309 · DOI
  6. Chen, Exosomal Circshkbp1 participates in non-small cell lung cancer progression through pkm2-mediated glycolysis, Mol. Ther. Oncolytics, 24, 470, 10.1016/j.omto.2022.01.012 · DOI
  7. Chen, 2020, Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome, Inflamm. Res., 69, 883, 10.1007/s00011-020-01378-2 · DOI
  8. Chen, 2023, Irradiated lung cancer cell-derived exosomes modulate macrophage polarization by inhibiting Mid1 via mir-4655-5p, Mol. Immunol., 155, 58, 10.1016/j.molimm.2023.01.009 · DOI
  9. Chen, Naringenin suppresses beas-2b-derived extracellular vesicular cargoes disorder caused by cigarette smoke extract thereby inhibiting M1 macrophage polarization, Front. Immunol., 13, 930476, 10.3389/fimmu.2022.930476 · DOI
  10. Cheng, Mettl3-Mediated M6a modification of Zbtb4 mrna is involved in the smoking-induced emt in cancer of the lung, Mol. Ther. Nucleic Acids, 23, 487, 10.1016/j.omtn.2020.12.001 · DOI
  11. Cheng, Macrophages in lung injury, repair, and fibrosis, Cells, 10, 436, 10.3390/cells10020436 · DOI
  12. Colombo, 2014, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, Annu. Rev. Cell Dev. Biol., 30, 255, 10.1146/annurev-cellbio-101512-122326 · DOI · Paper page
  13. Cui, 2022, Lung-specific exosomes for Co-delivery of Cd47 blockade and cisplatin for the treatment of non-small cell lung cancer, Thorac. Cancer, 13, 2723, 10.1111/1759-7714.14606 · DOI
  14. Deng, 2020, Bone marrow mesenchymal stem cell-derived exosomes attenuate lps-induced ards by modulating macrophage polarization through inhibiting glycolysis in macrophages, Shock, 54, 828, 10.1097/SHK.0000000000001549 · DOI
  15. Deng, 2022, Differential lung protective capacity of exosomes derived from human adipose tissue, bone marrow, and umbilical cord mesenchymal stem cells in sepsis-induced acute lung injury, Oxid. Med. Cell Longev., 2022, 7837837, 10.1155/2022/7837837 · DOI
  16. Dong, Exosomes from human umbilical cord mesenchymal stem cells attenuate the inflammation of severe steroid-resistant asthma by reshaping macrophage polarization, Stem Cell Res. Ther., 12, 204, 10.1186/s13287-021-02244-6 · DOI
  17. Dong, 2022, Mitochondrial metabolism mediated macrophage polarization in chronic lung diseases, Pharmacol. Ther., 239, 108208, 10.1016/j.pharmthera.2022.108208 · DOI
  18. Dong, Glioma glycolipid metabolism: msi2-snord12b-fip1l1-zbtb4 feedback loop as a potential treatment target, Clin. Transl. Med., 11, e411, 10.1002/ctm2.411 · DOI
  19. Esser, 2010, Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration, J. Allergy Clin. Immunol., 126, 1032, 10.1016/j.jaci.2010.06.039 · DOI
  20. Feng, 2023, Exosomal stimate derived from type ii alveolar epithelial cells controls metabolic reprogramming of tissue-resident alveolar macrophages, Theranostics, 13, 991, 10.7150/thno.82552 · DOI
  21. Feng, 2021, Epithelium- and endothelium-derived exosomes regulate the alveolar macrophages by targeting Rgs1 mediated calcium signaling-dependent immune response, Cell Death Differ., 28, 2238, 10.1038/s41418-021-00750-x · DOI
  22. Gan, 2022, The relationship between serum exosome hbv-mir-3 and current virological markers and its dynamics in chronic hepatitis B patients on antiviral treatment, Ann. Transl. Med., 10, 536, 10.21037/atm-22-2119 · DOI
  23. Gopalakrishnan, 2022, Protection against influenza-induced acute lung injury (ali) by enhanced induction of M2a macrophages: possible role of pparγ/Rxr ligands in il-4-induced M2a macrophage differentiation, Front. Immunol., 13, 968336, 10.3389/fimmu.2022.968336 · DOI
  24. Guan, 2023, M2 macrophage-derived exosomal mir-1911-5p promotes cell migration and invasion in lung adenocarcinoma by down-regulating Celf2 -activated Zbtb4 expression, Anticancer Drugs, 34, 238, 10.1097/CAD.0000000000001414 · DOI
  25. Guiot, 2020, Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic mir-142-3p, Thorax, 75, 870, 10.1136/thoraxjnl-2019-214077 · DOI
  26. Gunassekaran, 2021, M1 macrophage exosomes engineered to foster M1 polarization and target the il-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages, Biomaterials, 278, 121137, 10.1016/j.biomaterials.2021.121137 · DOI
  27. Gurunathan, 2021, A comprehensive review on factors influences biogenesis, functions, therapeutic and clinical implications of exosomes, Int. J. Nanomedicine, 16, 1281, 10.2147/IJN.S291956 · DOI
  28. Harrell, 2020, Molecular and cellular mechanisms responsible for beneficial effects of mesenchymal stem cell-derived product "Exo-D-Mapps" in attenuation of chronic airway inflammation, Anal. Cell Pathol. (Amst), 2020, 3153891, 10.1155/2020/3153891 · DOI
  29. He, 2019, Bronchial epithelial cell extracellular vesicles ameliorate epithelial-mesenchymal transition in copd pathogenesis by alleviating M2 macrophage polarization, Nanomedicine, 18, 259, 10.1016/j.nano.2019.03.010 · DOI
  30. Hu, 2022, Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer, Front. Immunol., 13, 1007812, 10.3389/fimmu.2022.1007812 · DOI
  31. Hu, 2023, Linc00963 promotes the malignancy and metastasis of lung adenocarcinoma by stabilizing Zeb1 and exosomes-induced M2 macrophage polarization, Mol. Med., 29, 1, 10.1186/s10020-022-00598-y · DOI
  32. Jiang, 2022, Zeb1-Induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer, Cell Death Dis., 13, 206, 10.1038/s41419-022-04632-z · DOI
  33. Jiang, 2023, Serum exosome-derived mir-7 exacerbates chronic obstructive pulmonary disease by regulating macrophage differentiation, Iran. J. Public Health, 52, 563, 10.18502/ijph.v52i3.12139 · DOI
  34. Jin, 2022, Hypoxic lung cancer cell-derived exosomal mir-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting Irf1, World J. Surg. Oncol., 20, 241, 10.1186/s12957-022-02706-y · DOI
  35. Junior, 2021, Mertk+/Hi M2c macrophages induced by baicalin alleviate non-alcoholic fatty liver disease, Int. J. Mol. Sci., 22, 10604, 10.3390/ijms221910604 · DOI
  36. Kalluri, 2020, The Biology, function, and biomedical applications of exosomes, Science, 367, eaau6977, 10.1126/science.aau6977 · DOI · Paper page
  37. Kaneda, 2016, Pi3kγ is a molecular switch that controls immune suppression, Nature, 539, 437, 10.1038/nature19834 · DOI
  38. Kim, 2018, Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations, Nanomedicine, 14, 195, 10.1016/j.nano.2017.09.011 · DOI · Paper page
  39. Kong, 2022, Cancer cell-derived exosomal Linc00313 induces M2 macrophage differentiation in non-small cell lung cancer, Clin. Transl. Oncol., 24, 2395, 10.1007/s12094-022-02907-7 · DOI
  40. Kulshreshtha, 2013, Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation, J. Allergy Clin. Immunol., 131, 1194, 10.1016/j.jaci.2012.12.1565 · DOI
  41. Lee, 2021, The role of macrophages in the development of acute and chronic inflammatory lung diseases, Cells, 10, 897, 10.3390/cells10040897 · DOI
  42. Lei, 2021, M2 macrophages-derived exosomal microrna-501-3p promotes the progression of lung cancer via targeting wd repeat domain 82, Cancer Cell Int., 21, 91, 10.1186/s12935-021-01783-5 · DOI
  43. Li, Microrna-370 carried by M2 macrophage-derived exosomes alleviates asthma progression through inhibiting the fgf1/mapk/stat1 Axis, Int. J. Biol. Sci., 17, 1795, 10.7150/ijbs.59715 · DOI
  44. Li, 2020, M1 macrophage-derived exosome-encapsulated cisplatin can enhance its anti-lung cancer effect, Minerva Med., 114, 634, 10.23736/S0026-4806.20.06564-7 · DOI
  45. Li, Batf3 promotes malignant phenotype of colorectal cancer through the S1pr1/P-Stat3/Mir-155-3p/Wdr82 Axis, Cancer Gene Ther., 28, 400, 10.1038/s41417-020-00223-2 · DOI
  46. Li, Tumor-associated macrophages secret exosomal mir-155 and mir-196a-5p to promote metastasis of non-small-cell lung cancer, Transl. Lung Cancer Res., 10, 1338, 10.21037/tlcr-20-1255 · DOI
  47. Li, Mir-21-5p in macrophage-derived exosomes targets Smad7 to promote epithelial mesenchymal transition of airway epithelial cells, J. Asthma Allergy, 14, 513, 10.2147/JAA.S307165 · DOI
  48. Liang, 2020, Cancer-derived exosomal Trim59 regulates macrophage Nlrp3 inflammasome activation to promote lung cancer progression, J. Exp. Clin. Cancer Res., 39, 176, 10.1186/s13046-020-01688-7 · DOI
  49. Liang, 2022, M2-Phenotype tumour-associated macrophages upregulate the expression of prognostic predictors Mmp14 and inhba in pancreatic cancer, J. Cell Mol. Med., 26, 1540, 10.1111/jcmm.17191 · DOI
  50. Lin, 2023, Two birds with One stone" strategy for the lung cancer therapy with bioinspired aie aggregates, J. Nanobiotechnology, 21, 49, 10.1186/s12951-023-01799-1 · DOI
  51. Liu, An inhalable hybrid biomimetic nanoplatform for sequential drug release and remodeling lung immune homeostasis in acute lung injury treatment, ACS Nano, 17, 11626, 10.1021/acsnano.3c02075 · DOI
  52. Liu, Prps2 enhances resistance to cisplatin via facilitating exosomes-mediated macrophage M2 polarization in non-small cell lung cancer, Immunol. Invest., 51, 1423, 10.1080/08820139.2021.1952217 · DOI
  53. Liu, 2018, H3k4me3 and Wdr82 are associated with tumor progression and a favorable prognosis in human colorectal cancer, Oncol. Lett., 16, 2125, 10.3892/ol.2018.8902 · DOI
  54. Liu, Tumor cell-derived exosomal mir-770 inhibits M2 macrophage polarization via targeting Map3k1 to inhibit the invasion of non-small cell lung cancer cells, Front. Cell Dev. Biol., 9, 679658, 10.3389/fcell.2021.679658 · DOI
  55. Liu, Medicinal plant-derived mtdna via nanovesicles induces the cgas-sting pathway to remold tumor-associated macrophages for tumor regression, J. Nanobiotechnology, 21, 78, 10.1186/s12951-023-01835-0 · DOI · Paper page
  56. Liu, Bmsc-derived exosomes ameliorate lps-induced acute lung injury by mir-384-5p-controlled alveolar macrophage autophagy, Oxid. Med. Cell Longev., 2021, 9973457, 10.1155/2021/9973457 · DOI
  57. Liu, Exosomal Circpvt1 derived from lung cancer promotes the progression of lung cancer by targeting mir-124-3p/ezh2 Axis and regulating macrophage polarization, Cell Cycle, 21, 514, 10.1080/15384101.2021.2024997 · DOI
  58. Liu, 2023, A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication, Cell Commun. Signal, 21, 77, 10.1186/s12964-023-01103-6 · DOI
  59. Long, 2021, Tumor-associated macrophages induced spheroid formation by ccl18-zeb1-M-csf feedback loop to promote transcoelomic metastasis of ovarian cancer, J. Immunother. Cancer, 9, e003973, 10.1136/jitc-2021-003973 · DOI
  60. Ma, 2010, The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time, BMC Cancer, 10, 112, 10.1186/1471-2407-10-112 · DOI
  61. Mansouri, 2019, Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes, JCI Insight, 4, e128060, 10.1172/jci.insight.128060 · DOI
  62. Mathivanan, 2010, Exosomes: extracellular organelles important in intercellular communication, J. Proteomics, 73, 1907, 10.1016/j.jprot.2010.06.006 · DOI
  63. Melo, 2021, Pulmonary macrophages and their different roles in health and disease, Int. J. Biochem. Cell Biol., 141, 106095, 10.1016/j.biocel.2021.106095 · DOI
  64. Merten, 1999, Platelet microparticles promote platelet interaction with subendothelial Matrix in a glycoprotein iib/iiia-dependent mechanism, Circulation, 99, 2577, 10.1161/01.cir.99.19.2577 · DOI
  65. Mohapatra, 2021, Non-coding rnas regulation of macrophage polarization in cancer, Mol. Cancer, 20, 24, 10.1186/s12943-021-01313-x · DOI
  66. Mondal, 2023, Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications, J. Control Release, 353, 1127, 10.1016/j.jconrel.2022.12.027 · DOI · Paper page
  67. Moon, 2015, Lung epithelial cell-derived extracellular vesicles activate macrophage-mediated inflammatory responses via Rock1 pathway, Cell Death Dis., 6, e2016, 10.1038/cddis.2015.282 · DOI
  68. Morrissey, 2021, Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming, Cell Metab., 33, 2040, 10.1016/j.cmet.2021.09.002 · DOI
  69. Niu, 2022, Macrophage derived mir-7219-3p-containing exosomes mediate fibroblast trans-differentiation by targeting Spry1 in silicosis, Toxicology, 479, 153310, 10.1016/j.tox.2022.153310 · DOI
  70. Pegtel, 2019, Exosomes, Annu. Rev. Biochem., 88, 487, 10.1146/annurev-biochem-013118-111902 · DOI · Paper page
  71. Peng, 2023, Exosomes derived from M1 macrophages inhibit the proliferation of the A549 and H1299 lung cancer cell lines via the mirna-let-7b-5p-gng5 Axis, PeerJ, 11, e14608, 10.7717/peerj.14608 · DOI
  72. Pritchard, 2020, Lung tumor cell-derived exosomes promote M2 macrophage polarization, Cells, 9, 1303, 10.3390/cells9051303 · DOI
  73. Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014 · DOI
  74. Qian, 2023, Exosomal circ-adrm1 promotes lung adenocarcinoma progression and induces macrophage M2 polarization through regulating Mmp14 mrna and protein, Anticancer Drugs, 34, 333, 10.1097/CAD.0000000000001430 · DOI
  75. Qian, 2022, Downregulated mir-129-5p expression inhibits rat pulmonary fibrosis by upregulating Stat1 gene expression in macrophages, Int. Immunopharmacol., 109, 108880, 10.1016/j.intimp.2022.108880 · DOI
  76. Qin, 2021, Macrophage-derived exosomes mediate silica-induced pulmonary fibrosis by activating fibroblast in an endoplasmic reticulum stress-dependent manner, J. Cell Mol. Med., 25, 4466, 10.1111/jcmm.16524 · DOI
  77. Qiu, 2022, Gastric cancer-derived exosomal mir-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis, J. Exp. Clin. Cancer Res., 41, 296, 10.1186/s13046-022-02499-8 · DOI
  78. Rao, 2022, Nlrp6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer, Cell Death Dis., 13, 891, 10.1038/s41419-022-05336-0 · DOI
  79. Ren, 2021, Intranasal delivery of msc-derived exosomes attenuates allergic asthma via expanding il-10 producing lung interstitial macrophages in mice, Int. Immunopharmacol., 91, 107288, 10.1016/j.intimp.2020.107288 · DOI
  80. Shang, 2020, Exosomes from Mmu_Circ_0001359-modified adscs attenuate airway remodeling by enhancing Foxo1 signaling-mediated M2-like macrophage activation, Mol. Ther. Nucleic Acids, 19, 951, 10.1016/j.omtn.2019.10.049 · DOI
  81. Shao, 2023, Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion, Front. Immunol., 14, 1161375, 10.3389/fimmu.2023.1161375 · DOI
  82. Shotland, 2021, Pulmonary macrophage cell death in lung health and disease, Am. J. Respir. Cell Mol. Biol., 64, 547, 10.1165/rcmb.2020-0420TR · DOI
  83. Song, 2019, Nets promote ali/ards inflammation by regulating alveolar macrophage polarization, Exp. Cell Res., 382, 111486, 10.1016/j.yexcr.2019.06.031 · DOI
  84. Song, 2023, M2 macrophages-derived exosomal mir-3917 promotes the progression of lung cancer via targeting Grk6, Biol. Chem., 404, 41, 10.1515/hsz-2022-0162 · DOI
  85. Sun, Clodronate-loaded liposomal and fibroblast-derived exosomal hybrid system for enhanced drug delivery to pulmonary fibrosis, Biomaterials, 271, 120761, 10.1016/j.biomaterials.2021.120761 · DOI
  86. Sun, Macrophage exosomes transfer angiotensin ii type 1 receptor to lung fibroblasts mediating bleomycin-induced pulmonary fibrosis, Chin. Med. J. Engl., 134, 2175, 10.1097/CM9.0000000000001605 · DOI
  87. Tang, 2022, Scorpion and centipede alleviates severe asthma through M2 macrophage-derived exosomal mir-30b-5p, Aging (Albany NY), 14, 3921, 10.18632/aging.204053 · DOI
  88. TJonck, 2023, The role of monocyte-derived macrophages in the lung: it's all about context, Int. J. Biochem. Cell Biol., 159, 106421, 10.1016/j.biocel.2023.106421 · DOI
  89. van der Pol, 2012, Classification, functions, and clinical relevance of extracellular vesicles, Pharmacol. Rev., 64, 676, 10.1124/pr.112.005983 · DOI
  90. Wan, 2022, Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through mstrg.292666.16-mir-6836-5p-mapk8ip3 Axis, Cancer Cell Int., 22, 83, 10.1186/s12935-022-02509-x · DOI
  91. Wang, 2020, Exosomes derived from macrophages enhance aerobic glycolysis and chemoresistance in lung cancer by stabilizing C-myc via the inhibition of Nedd4l, Front. Cell Dev. Biol., 8, 620603, 10.3389/fcell.2020.620603 · DOI
  92. Wang, 2021, Cigarette smoke extract-treated airway epithelial cells-derived exosomes promote M1 macrophage polarization in chronic obstructive pulmonary disease, Int. Immunopharmacol., 96, 107700, 10.1016/j.intimp.2021.107700 · DOI
  93. Wang, 2023, A targeted exosome therapeutic confers both cfdna scavenging and macrophage polarization for ameliorating rheumatoid arthritis, Adv. Mater, 35, e2302503, 10.1002/adma.202302503 · DOI
  94. Willis, 2018, Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation, Am. J. Respir. Crit. Care Med., 197, 104, 10.1164/rccm.201705-0925OC · DOI
  95. Wolf, 1967, The nature and significance of platelet products in human plasma, Br. J. Haematol., 13, 269, 10.1111/j.1365-2141.1967.tb08741.x · DOI
  96. Wu, 2022, Effect of modified jianpi yangzheng on regulating content of Pkm2 in gastric cancer cells-derived exosomes, Phytomedicine, 103, 154229, 10.1016/j.phymed.2022.154229 · DOI
  97. Xu, 2021, Progress of exosomes in the diagnosis and treatment of lung cancer, Biomed. Pharmacother. = Biomedecine Pharmacother., 134, 111111, 10.1016/j.biopha.2020.111111 · DOI
  98. Xu, 2022, Role of exosomal non-coding rnas from tumor cells and tumor-associated macrophages in the tumor microenvironment, Mol. Ther., 30, 3133, 10.1016/j.ymthe.2022.01.046 · DOI
  99. Yan, 2022, Tumor cell-derived exosomal microrna-146a promotes non-small cell lung cancer cell invasion and proliferation by inhibiting M1 macrophage polarization, Ann. Transl. Med., 10, 1307, 10.21037/atm-22-5565 · DOI
  100. Yang, 2019, Exosomes derived from M2b macrophages attenuate dss-induced colitis, Front. Immunol., 10, 2346, 10.3389/fimmu.2019.02346 · DOI
  101. Yang, 2023, Identification of Zbtb4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer, BMC Cancer, 23, 263, 10.1186/s12885-023-10749-x · DOI
  102. Yao, 2019, Microrna-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via Fam13a in a rat model, Exp. Mol. Med., 51, 1, 10.1038/s12276-019-0255-x · DOI
  103. Ye, 2020, Alveolar macrophage - derived exosomes modulate severity and outcome of acute lung injury, Aging (Albany NY), 12, 6120, 10.18632/aging.103010 · DOI
  104. Ye, 2018, Long non-coding rna cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization, J. Cell Biochem., 119, 2951, 10.1002/jcb.26509 · DOI
  105. Yu, 2021, Increased airway epithelial cell-derived exosomes activate macrophage-mediated allergic inflammation via Cd100 shedding, J. Cell Mol. Med., 25, 8850, 10.1111/jcmm.16843 · DOI
  106. Yuan, 2022, Tumor-associated macrophage-derived exosomes promote egfr-tki resistance in non-small cell lung cancer by regulating the akt, erk1/2 and Stat3 signaling pathways, Oncol. Lett., 24, 356, 10.3892/ol.2022.13476 · DOI
  107. Yuan, 2018, Bronchoalveolar lavage exosomes in lipopolysaccharide-induced septic lung injury, J. Vis. Exp., 57737, 10.3791/57737 · DOI
  108. Zaiets, 2023, Sera of individuals chronically infected with hepatitis B virus (hbv) contain diverse rna types produced by hbv replication or derived from integrated hbv DNA, J. Virol., 97, e0195022, 10.1128/jvi.01950-22 · DOI
  109. Zhang, M2 macrophage-derived exosomal long non-coding rna agap2-as1 enhances radiotherapy immunity in lung cancer by reducing microrna-296 and elevating Notch2, Cell Death Dis., 12, 467, 10.1038/s41419-021-03700-0 · DOI
  110. Zhang, 2023, In situ reprogramming of tumor-associated macrophages with internally and externally engineered exosomes, Angew. Chem. Int. Ed. Engl., 62, e202217089, 10.1002/anie.202217089 · DOI
  111. Zhang, 2018, Macrophages: friend or foe in idiopathic pulmonary fibrosis?, Respir. Res., 19, 170, 10.1186/s12931-018-0864-2 · DOI
  112. Zhang, 2017, Rassf4 overexpression inhibits the proliferation, invasion, emt, and wnt signaling pathway in osteosarcoma cells, Oncol. Res., 25, 83, 10.3727/096504016X14719078133447 · DOI
  113. Zhang, 2023, Tumor-associated macrophage subsets: shaping polarization and targeting, Int. J. Mol. Sci., 24, 7493, 10.3390/ijms24087493 · DOI
  114. Zhang, Macrophage-mediated vascular permeability via vla4/vcam1 pathway dictates ascites development in ovarian cancer, J. Clin. Invest., 131, e140315, 10.1172/JCI140315 · DOI
  115. Zhang, Otud5-Mediated deubiquitination of yap in macrophage promotes M2 phenotype polarization and favors triple-negative breast cancer progression, Cancer Lett., 504, 104, 10.1016/j.canlet.2021.02.003 · DOI
  116. Zhao, 2022, Microfluidic-based exosome isolation and highly sensitive aptamer exosome membrane protein detection for lung cancer diagnosis, Biosens. Bioelectron., 214, 114487, 10.1016/j.bios.2022.114487 · DOI
  117. Zhou, 2022, Hypoxic tumor-derived exosomes induce M2 macrophage polarization via pkm2/ampk to promote lung cancer progression, Cell Transpl., 31, 9636897221106998, 10.1177/09636897221106998 · DOI
  118. Zhou, 2021, Exosomes derived from induced pluripotent stem cells suppresses M2-type macrophages during pulmonary fibrosis via mir-302a-3p/tet1 Axis, Int. Immunopharmacol., 99, 108075, 10.1016/j.intimp.2021.108075 · DOI
  119. Zhu, 2020, Isolation and characterization of exosomes for cancer research, J. Hematol. Oncol., 13, 152, 10.1186/s13045-020-00987-y · DOI
  120. Zhu, 2022, Exosomes derived from adipose-derived stem cells alleviate cigarette smoke-induced lung inflammation and injury by inhibiting alveolar macrophages pyroptosis, Respir. Res., 23, 5, 10.1186/s12931-022-01926-w · DOI

Cited by

Sorted by citations

See all 22

Metadata

Authors
Kang, J., Hua, P., Wu, X., & Wang, B.
Venue
Frontiers in Cell and Developmental Biology
Publisher
Frontiers Media SA
Published
2024-04-09
Volume
12
ISSN
2296-634X
DOI
10.3389/fcell.2024.1271684
PMC
PMC11035777
Cited by
22
References
3
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exosomes: efficient macrophage-related immunomodulators in chronic lung diseases. https://app.cochat.ai/papers/10.3389/fcell.2024.1271684
The paper
Kang, J., Hua, P., Wu, X., & Wang, B. (2024). Exosomes: efficient macrophage-related immunomodulators in chronic lung diseases. Frontiers in Cell and Developmental Biology. https://doi.org/10.3389/fcell.2024.1271684